QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 aytu-biopharma-q3-2024-gaap-eps-052-beats-064-estimate-sales-17993m-beat-17346m-estimate

Aytu BioPharma (NASDAQ:AYTU) reported quarterly losses of $(0.52) per share which beat the analyst consensus estimate of $(0.64...

 aytu-biopharma-q2-2024-gaap-eps-004-beats-025-estimate-sales-2293m-beat-2175m-estimate

Aytu BioPharma (NASDAQ:AYTU) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.25...

 earnings-scheduled-for-february-14-2024

Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is projected to report quarterly earnings at $1.65 per share on r...

 earnings-preview-aytu-biopharma
Earnings Preview: Aytu BioPharma
02/13/2024 19:02:10

 why-shapeways-holdings-shares-are-trading-lower-by-around-20-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Shapeways Holdings, Inc. (NASDAQ: SHPW) tumbled during Wednesday’s session following downbeat results.

 aytu-biopharma-q1-eps-148-down-from-120-yoy-sales-2210m-miss-2773m-estimate

Aytu BioPharma (NASDAQ:AYTU) reported quarterly losses of $(1.48) per share. This is a 23.33 percent decrease over losses of $(...

 earnings-scheduled-for-november-14-2023

Companies Reporting Before The Bell • CureVac (NASDAQ:CVAC) is likely to report quarterly loss at $0.24 per share on revenue o...

 biggest-short-squeeze-stocks-of-the-week-biotech-stocks-dominate-a-bitcoin-related-stock-moves-up-leaderboard

Potential short squeeze plays gained steam in 2021, continued throughout 2022 and remained a focus of traders looking for the n...

 aytu-biopharma-announces-approval-of-the-cotempla-xr-odt-manufacturing-site-transfer-prior-approval-supplement

U.S. Food & Drug Administration Approval of the Prior Approval Supplement (PAS) Enables Transfer of Cotempla Production to ...

 why-carmax-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-thursdays-mid-day-session

Gainers Bionomics Limited (NASDAQ: BNOX) shares jumped 308% to $4.00 after the company announced the ATTUNE trial met its p...

 reported-september-27-aytu-biopharma-q4-eps-059-beats-095-estimate-sales-3073m-beat-2769m-estimate

Aytu BioPharma (NASDAQ:AYTU) reported quarterly losses of $(0.59) per share which beat the analyst consensus estimate of $(0.95...

 earnings-scheduled-for-september-27-2023

Companies Reporting Before The Bell • Paychex (NASDAQ:PAYX) is projected to report quarterly earnings at $1.12 per share on re...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION